Breaking Respiratory Research Findings From Propeller Health Unveiled at ERS 2022

Propeller Health and its research partners presented five abstracts at this year’s European Respiratory Society (ERS) International Congress. Our latest research explored the relationship between respiratory comorbidities and healthcare utilization, the effect of digital health solutions on medication adherence and asthma control, and projected prevalence of COPD by the year 2050.

Read brief summaries of each abstract below or click the links to view them online.

Characterizing healthcare resource use among adults with COPD by presence of comorbidities

Chronic respiratory patients prefer seeking environmental information from mobile apps

Environmental factors, such as air pollution and pollen levels, are influences known to significantly impact overall health. For patients with chronic respiratory conditions, these environmental factors can be triggers that mark the difference between a symptom-free day and an emergency room visit.1,2 However, despite their known health impacts, little research had been done to understand how people with chronic respiratory disease perceive and seek information regarding environmental risks – until now.

A study recently published in Frontiers in Digital Health – one of the first digital health studies to survey and evaluate patient perceptions of environmental influences – demonstrated that a majority of patients with asthma and COPD believe that a handful of specific environmental factors may make their symptoms worse. 

An analysis of survey responses collected from nearly 700 participants, all of whom use Propeller’s precision digital health platform to manage their chronic respiratory conditions, showed that pollen, mold, second-hand smoke and air pollution were the leading environmental factors perceived by users to worsen their symptoms. 

Symptom-related disruptions and rescue inhaler use decreases among Propeller users with asthma

In a recent Propeller Health study, we observed that patients with asthma who used a digital health platform had significant improvements in rescue inhaler use and self-reported activity rates over three months.

Data was captured using Propeller’s digital health platform, which includes an inhaler sensor that passively collects medication use data and a mobile app that engages patients in chronic condition self-management. To help keep patients and their clinicians informed about their asthma control status, the Propeller platform prompts patients to complete the Asthma Control Test™ (ACT™) within the mobile app on a monthly basis.1

New Propeller Health data on patient behavior to be revealed at SBM 2022

Research continues to show how positive behavior change can play an important role in improving health outcomes, especially among patients with chronic conditions such as asthma and COPD. With three peer-reviewed abstracts accepted for presentation at the Society of Behavioral Medicine (SBM) 2022 Annual Meeting on April 6-9, Propeller Health’s recent findings on patient behavior – as they relate to the pandemic, digital health use and smoking prevalence – add to this growing body of knowledge.

Read brief summaries of each abstract below or click the links to view them online.

Propeller Health accelerates push towards value-based care with new digital health solutions for patients, providers and health systems

Announces integrations with multiple leading Electronic Health Record (EHR) systems, introduces a new solution to enable Remote Therapeutic Monitoring (RTM) by healthcare providers, and launches digital platform updates to enable respiratory care at home, in-clinic, and on-the-go.

MIAMI, March 7, 2022 – Propeller Health, a leader in digital health for asthma and chronic obstructive pulmonary disease (COPD), today announced three exciting updates and new solutions to bring its clinically proven, FDA-cleared platform to more patients, providers and health systems.

Integrations expand the reach of Propeller’s digital platform to more health systems
Reducing dose frequency may help improve asthma medication adherence

Findings from a Propeller Health study recently published in The Journal of Allergy and Clinical Immunology demonstrated that patients with asthma who are prescribed once-daily dosing schedules are more likely to adhere to their controller medications than those with twice-daily prescriptions.

Medication adherence data was collected from 6,410 patients who used the Propeller digital health platform. The platform’s inhaler sensors attach to a patient’s inhaler medications and passively capture the date and time of controller medication use. 

The majority of patients find remote care helpful. Clinicians can benefit from patient use, too.

More and more patients with chronic conditions like asthma have adopted remote care and digital health tools to self-manage their conditions since the start of the COVID-19 pandemic. Survey results from a recent Propeller Health study to be presented at the 2022 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting found that the majority of patients (68.7%) find their use of remote care helpful. Of the 441 patients surveyed, about one third of patients reported that they connected with their asthma providers through video visits and messaging services.

This uptake in digital therapeutic and remote care adoption by patients has potentially significant benefits for clinicians as well. 

Latest Propeller Health findings on asthma care to be presented at AAAAI 2022

This year, the American Academy of Allergy, Asthma and Immunology (AAAAI) has accepted four abstracts authored by Propeller Health and its research partners.

Our latest findings on asthma care, including how simplified dose frequency may increase medication adherence and how digital health can support improved pediatric asthma outcomes, will be presented at the AAAAI Annual Meeting on February 25-28. Read brief summaries of each abstract below or click the links to view them online.

Medication adherence doubles when patients use digital health apps

The most successful digital health platforms deliver improved outcomes by creating lasting, sustainable behavior changes in patients. These platforms often integrate smartphone apps into their solutions, empowering patients to be more proactive in maintaining their health and helping drive patient engagement — both essential for the self-management of chronic diseases such as asthma and COPD. But to what extent are digital health apps effective in influencing patient behavior, particularly around medication adherence?

In a study recently published in Nature’s Scientific Reports, Propeller Health found that controller medication adherence among patients with chronic respiratory disease was more likely to increase (up to twofold) with digital health app engagement. Data was collected from a study group that included 1,629 participants with asthma and 663 participants with COPD who were using the Propeller platform. App engagement was measured by how often the Propeller app was opened and the amount of time participants spent in the app, perhaps interacting with features such as educational content or personalized insights. 

No Posts Here :(